• In order to minimise harm to healthy tissues during cancer therapy, nanoparticles can be designed for focused drug delivery. • By increasing a drug's solubility, stability, and bioavailability, nanoparticles may minimise negative effects and enable lower dosages. • Multiple therapeutic compounds can be co-delivered using nanoparticles, improving treatment outcomes and producing synergistic effects.
No takes yet. Share an insight, caveat, or question.
Subashini et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: